Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease

References

• Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, Rajaram R, Rauws EA, Mulder CJ, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a dutch population. Gut 2002;51:562–6.
   PubMed Web of Science ®Google Scholar
• Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden. Hepatology 2010;52:571–7.
   PubMed Web of Science ®Google Scholar
• Tischendorf JJ, Hecker H, Kruger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol 2007;102:107–14.
   PubMed Web of Science ®Google Scholar
• Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2270–6.
   PubMed Web of Science ®Google Scholar
• Bergeron V, Vienne A, Sokol H, Seksik P, Nion-Larmurier I, Ruskone-Fourmestraux A, et al. Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis. Am J Gastroenterol 2010;105:2405–11.
   Google Scholar
• Loftus EVJr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91–6.
   PubMed Web of Science ®Google Scholar
• Ngu JH, Gearry RB, Wright AJ, Stedman CA. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2011;9:1092–7.
   PubMed Web of Science ®Google Scholar
• Thackeray EW, Charatcharoenwitthaya P, Elfaki D, Sinakos E, Lindor KD. Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2011;9:52–6.
   PubMed Web of Science ®Google Scholar
• Claessen MM, Lutgens MW, van Buuren HR, Oldenburg B, Stokkers PC, van der Woude CJ, et al. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis 2009;15:1331–6.
   PubMed Web of Science ®Google Scholar
• Rudolph G, Gotthardt D, Kloeters-Plachky P, Rost D, Kulaksiz H, Stiehl A. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival. J Hepatol 2010;53:313–17.
   PubMed Web of Science ®Google Scholar
• Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321–7.
   PubMed Web of Science ®Google Scholar
• Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 swedish patients with primary sclerosing cholangitis. Gut 1996;38:610–15.
   PubMed Web of Science ®Google Scholar
• Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013;58:2045–55.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Lind GE. Primary sclerosing cholangitis and malignancy. Baillieres Best Pract Res Clin Gastroenterol 2011;25:753–64.
   PubMed Web of Science ®Google Scholar
• Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009;50:158–64.
   PubMed Web of Science ®Google Scholar
• Karlsen TH. The Nordic Liver Transplant Registry (NLTR). Annual report 2012.
   Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6.
   PubMedGoogle Scholar
• Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European Crohn’s and Colitis Organisation (ECCO). European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis 2008;2:1–23.
   PubMed Web of Science ®Google Scholar
• Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of crohn’s disease: Definitions and diagnosis. Gut 2006;55:1–15.
   PubMed Web of Science ®Google Scholar
• Geboes K, Van Eyken P. Inflammatory bowel disease unclassified and indeterminate colitis: The role of the pathologist. J Clin Pathol 2009;62:201–5.
   PubMed Web of Science ®Google Scholar
• Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660–78.
   PubMed Web of Science ®Google Scholar
• Wiesner RH, Ludwig J, LaRusso NF, MacCarty RL. Diagnosis and treatment of primary sclerosing cholangitis. Semin Liver Dis 1985;5:241–53.
   PubMed Web of Science ®Google Scholar
• Jones HW, Grogono J, Hoare AM. Surveillance in ulcerative colitis: Burdens and benefit. Gut 1988;29:325–31.
   PubMed Web of Science ®Google Scholar
• Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815–22.
   PubMed Web of Science ®Google Scholar
• Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 2011;54:1842–52.
   PubMed Web of Science ®Google Scholar
• Aitola P, Mattila J, Matikainen M. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma. Int J Colorectal Dis 2000;15:167–71.
   PubMed Web of Science ®Google Scholar
• Imam MH, Thackeray EW, Lindor KD. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis. Colorectal Dis 2013;15:198–203.
   Google Scholar
• Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:746–74.
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666–89.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second european evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: Special situations. J Crohns Colitis 2013;7:1–33.
   PubMed Web of Science ®Google Scholar
• Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyoty M, Nieminen I, et al. The risk of colorectal cancer in patients with inflammatory bowel diseases in finland: A follow-up of 20 years. J Crohns Colitis 2013;7:e551–7.
   Google Scholar
• Jussila A, Virta LJ, Pukkala E, Farkkila MA. Malignancies in patients with inflammatory bowel disease: A nationwide register study in Finland. Scand J Gastroenterol 2013;48:1405–13.
   PubMed Web of Science ®Google Scholar